Non-infectious pulmonary complications after bone marrow transplantation
- Department of Pulmonary and Critical Care Medicine, Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA
- Correspondence and reprint requests to: Dr Imtiaz Khurshid, Department of Pulmonary and Critical Care Medicine, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA; khurshidi{at}mail.ecu.edu
- Received 22 June 2001
- Accepted 7 January 2001
Abstract
Bone marrow transplantation (BMT) is a successful and recognised treatment option for patients with a number of haematological and non-haematological malignant and non-malignant conditions. Pulmonary complications both infectious and non-infectious are common after BMT. Multiple factors are thought to contribute to pulmonary complications, including the type and duration of immunological defects produced by the underlying disease and treatment, the development of graft-versus-host disease (GVHD), and the conditioning regimens employed. These complications are classified as early or late, depending on whether they occur before or after 100 days from transplantation. Early non-infectious pulmonary complications typically include pulmonary oedema, upper airway complications, diffuse alveolar haemorrhage, cytolytic thrombi, and pleural effusion. Bronchiolitis obliterans, veno-occlusive disease, and secondary malignancies occur late after BMT. Idiopathic pneumonia syndrome, GVHD, and radiation induced lung injury can occur in early or late period after BMT.
- BMT, bone marrow transplantation
- DAH, diffuse alveolar haemorrhage
- GVHD, graft-versus-host disease
- IPS, idiopathic pneumonia syndrome







